Exposure to oral oxycodone is increased by concomitant inhibition of CYP2D6 and 3A4 pathways, but not by inhibition of CYP2D6 alone



: Gronlund J, Saari TI, Hagelberg NM, Neuvonen PJ, Olkkola KT, Laine K

Publisher: WILEY-BLACKWELL

: 2010

: British Journal of Clinical Pharmacology

: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

: BRIT J CLIN PHARMACO

: 1

: 70

: 1

: 78

: 87

: 10

: 0306-5251

DOI: https://doi.org/10.1111/j.1365-2125.2010.03653.x


Drug interactions arising from CYP2D6 inhibition most likely have minor clinical importance for oral oxycodone if the function of the CYP3A4 pathway is normal. When both CYP2D6 and CYP3A4 pathways are inhibited, the exposure to oral oxycodone is increased substantially.



Last updated on 2024-26-11 at 11:36